Vinnova awards Reccan a grant for support with regulatory documentation
Vinnova has awarded Reccan a grant of SEK 200,000 for the development of technical documentation. This support was obtained through the Medtech4Health call 2023, aiming at strengthening the competence in small medtech companies.
Reccan strives to improve the prognosis for pancreatic cancer patients by launching a new diagnostic test. The grant will be used for competence enhancement within the regulatory field, for the finalization of the technical documentation necessary for market introduction. External expertise in regulatory will be engaged.
The goal is to, through increased knowledge and understanding, meet the regulatory eligibility requirements set for IVD (in vitro diagnostic) products as well as to compile the technical documentation for certification of Reccan’s products.
“We are thrilled to receive yet another grant from Vinnova. This support enables us to bring in expert competences needed for this important milestone on our way to launch a product to the market. “, says Malin Bornschein CEO of Reccan.
About Vinnova
Vinnova is the Swedish governmental agency for innovation systems with the mission to boost sustainable growth. This is primarily executed by funding innovation and research-related projects.
About Medtech4Health
Medtech4Health is a national Strategic Innovation Program within medical technology with a focus to implementing medical technologies to streamline healthcare and strengthen the medical technology industry, nationally and internationally. To make this possible, they bring together stakeholders in healthcare, academia, and business in different projects.
